You built your business. We protect what you have built when it is time to sell. Our Boston business exit attorneys represent owners selling companies across Biotech, Healthcare, Technology, providing strategic sell-side counsel that maximizes your value, protects your interests, and gets the deal across the finish line.
Our managing partner provides selective business exit & sell-side law counsel to clients in Boston and nationwide, including:
We engage selectively with capitalized founders and investors in Boston and nationwide:
Boston is the global epicenter of biotech and life sciences M&A, with Kendall Square and the Route 128 corridor housing the densest concentration of biotech companies outside San Francisco. Beyond life sciences, the region drives significant deal activity in financial technology, education technology, and defense contracting. The region's deep research university ecosystem (MIT, Harvard, Tufts) produces a steady stream of spinoff companies ripe for acquisition.
Boston's biotech-heavy deal market means acquirers often face complex IP due diligence involving university licenses, clinical trial data, and FDA regulatory considerations. Competition from large pharma strategic acquirers can push valuations higher for promising targets.
Boston's concentration of world-class research institutions and highly educated workforce creates a self-reinforcing ecosystem where acquired companies can access talent, partnerships, and capital unavailable in other markets.
Massachusetts enacted the Noncompetition Agreement Act in 2018, limiting non-competes to 12 months and requiring garden leave pay - buyers must evaluate existing employee agreements during due diligence as many pre-2018 agreements may now be unenforceable.
We specialize in biotech and life sciences securities transactions, understanding the unique regulatory and scientific complexities of this sector.
A structured, methodical approach to business exit & sell-side law
We assess your corporate records, contracts, and legal standing to identify issues that could reduce your sale price or delay closing, and help you fix them before going to market.
We work with you and your advisors to define your priorities, whether that is maximizing cash at close, minimizing post-closing risk, retaining key terms, or achieving a clean break.
We analyze incoming offers and negotiate letter of intent terms that set you up for a successful transaction, including purchase price structure, exclusivity, and closing conditions.
Managing Partner Alex Lubyansky personally negotiates the definitive purchase agreement, fighting for seller-favorable terms on reps and warranties, indemnification, escrow, and closing mechanics.
We manage the closing process, coordinate with all parties, and handle transition services agreements and non-compete terms so you can exit on your terms.
"Sellers who wait until they have a buyer to think about legal structure end up leaving money on the table. The time to prepare for a sale is 12 to 18 months before you expect to close. Everything from tax structure to contract cleanup affects what a buyer will pay."
Restricted with 12-month cap and garden leave requirement. Sale-of-business exception.
Entity mergers and conversions require filing with the Massachusetts Secretary of the Commonwealth, Corporations Division. The Department of Revenue requires tax waivers for asset purchases. Professional corporations require additional filings with the relevant licensing board.
Submit your transaction details for a preliminary assessment by our managing partner.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Common questions from Boston clients
Submit your transaction details for a preliminary assessment by our managing partner
Submit Transaction DetailsIn-depth guides to help you prepare for your transaction
Key considerations for sellers navigating the M&A process with legal representation.
Read guideA structured approach to legal, financial, and operational due diligence.
Read guideUnderstanding the binding and non-binding elements of each document.
Read guideCommon deal-killers and how experienced counsel helps prevent them.
Read guideWhat buyers should look for in a Franchise Disclosure Document.
Read guideOur managing partner provides selective business exit & sell-side law counsel for transactions nationwide. Submit your transaction details for a preliminary assessment.
Submit transaction details for review. We engage selectively with capitalized buyers and sellers.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Selective M&A practice - Nationwide reach - Managing partner on every deal